Understanding Ureteropelvic Junction Obstruction From a Scientometric Perspective: How Is the Global Research Activity and Collaboration Going?

从科学计量学的角度理解输尿管肾盂交界处梗阻:全球研究活动和合作进展如何?

阅读:1

Abstract

OBJECTIVE: Ureteropelvic junction obstruction (UPJO) has been identified as the most prevalent cause of prenatally diagnosed hydronephrosis, characterized by a reduction in urine flow from the renal pelvis into the ureter. Management of this condition poses a significant clinical challenge, given the difficulty in differentiating between mild and benign cases and those with the potential to progress to severe renal impairment. This study is aimed at clarifying the global research activity and collaborative trends in UPJO research by undertaking a scientometric analysis, with the objective of providing valuable insights into the state of UPJO research. MATERIALS AND METHODS: Publications relevant to UPJO published between 1945 and 2024 were retrieved from the Web of Science Core Collection (WoSCC) database. The metrological software and graphing tools utilized included Bibliometrix 4.1.1, VOSviewer 1.6.20, GraphPad Prism 10, and Microsoft Excel 2020. RESULTS: A total of 1447 publications between 1948 and 2024 were included. The United States contributed the most publications (n = 456, 31.5%), and the most productive journal is the Journal of Urology (n = 340, 23.5%). The latest keywords "classification", "improvement", and "assisted laparoscopic pyeloplasty" mainly appeared since 2020. CONCLUSIONS: In recent decades, UPJO research has undergone consistent advancement, encompassing a multitude of disciplines and innovative therapeutic strategies. The predominant research initiatives have been concentrated in a select number of high-income countries. To facilitate further progress in this domain, there is a need to fortify international collaborations and promote translational research.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。